Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

Abstract

PURPOSE Here we report 5-year survival data from S9504, a Southwest Oncology Group phase II trial evaluating consolidation docetaxel after concurrent cisplatin/etoposide and thoracic radiation therapy in patients with pathologically documented stage IIIB non-small-cell lung cancer. Survival outcomes were compared with a predecessor study (S9019) with… (More)

Topics

Cite this paper

@article{Gandara2006LongtermSW, title={Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).}, author={David R. Gandara and Kari L Chansky and Kathy S. Albain and Laurie E. Gaspar and P. Lara and Karen Kelly and John Crowley and Robert B. Livingston}, journal={Clinical lung cancer}, year={2006}, volume={8 2}, pages={116-21} }